Teva Pharmaceutical Industries Ltd (TEVA)
13.19
+0.10
(+0.76%)
USD |
NYSE |
Apr 17, 16:00
13.15
-0.04
(-0.30%)
After-Hours: 20:00
Teva Pharmaceutical Industries Net Income (TTM): -559.00M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -559.00M |
| September 30, 2023 | -2.302B |
| June 30, 2023 | -2.326B |
| March 31, 2023 | -1.695B |
| December 31, 2022 | -2.445B |
| September 30, 2022 | -1.29B |
| June 30, 2022 | -1.054B |
| March 31, 2022 | -615.00M |
| December 31, 2021 | 417.00M |
| September 30, 2021 | 726.00M |
| June 30, 2021 | -3.915B |
| March 31, 2021 | -3.982B |
| December 31, 2020 | -3.99B |
| September 30, 2020 | -4.031B |
| June 30, 2020 | 4.00M |
| March 31, 2020 | -825.00M |
| December 31, 2019 | -999.00M |
| September 30, 2019 | -3.994B |
| June 30, 2019 | -3.888B |
| March 31, 2019 | -3.375B |
| December 31, 2018 | -2.15B |
| September 30, 2018 | -10.80B |
| June 30, 2018 | -9.996B |
| March 31, 2018 | -15.79B |
| December 31, 2017 | -16.26B |
| Date | Value |
|---|---|
| September 30, 2017 | -5.703B |
| June 30, 2017 | -5.886B |
| March 31, 2017 | 338.00M |
| December 31, 2016 | 329.00M |
| September 30, 2016 | 1.802B |
| June 30, 2016 | 1.493B |
| March 31, 2016 | 1.778B |
| December 31, 2015 | 1.588B |
| September 30, 2015 | 1.775B |
| June 30, 2015 | 2.548B |
| March 31, 2015 | 2.757B |
| December 31, 2014 | 3.055B |
| September 30, 2014 | 2.748B |
| June 30, 2014 | 2.583B |
| March 31, 2014 | 1.383B |
| December 31, 2013 | 1.269B |
| September 30, 2013 | 1.209B |
| June 30, 2013 | 419.00M |
| March 31, 2013 | 1.734B |
| December 31, 2012 | 1.963B |
| September 30, 2012 | 2.149B |
| June 30, 2012 | 3.144B |
| March 31, 2012 | 2.857B |
| December 31, 2011 | 2.759B |
| September 30, 2011 | 3.024B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-4.031B
Minimum
Sep 2020
726.00M
Maximum
Sep 2021
-1.935B
Average
-1.695B
Median
Mar 2023
Net Income (TTM) Benchmarks
| Viatris Inc | 54.70M |
| Johnson & Johnson | 35.15B |
| GSK PLC | 6.132B |
| Novartis AG | 14.85B |
| Sanofi SA | 5.859B |